CIK 0001376339
- Large accelerated filer
MIMEDX GROUP, INC.
Sign in to watch- Ticker
- MDXG
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 262792552
- Phone
- +1 770-651-9100
- Business address
- 1775 W OAK COMMONS COURT, NE, MARIETTA, GA, 30062
- Former names
- Alynx, Co.
- 4 Open-market sale General Counsel and CAO sold 11,308 shares at $4.24 ($47,998)
- 4 Open-market sale Chief Financial Officer sold 19,000 shares at $4.50 ($85,416)
- 4 Open-market sale General Counsel and CAO sold 15,555 shares at $4.53 ($70,477)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale Chief Financial Officer sold 4,992 shares at $2.82 ($14,053)
- 4 Grant or award Interim CEO acquired 200,000 shares (grant or award)
- 4 Open-market sale President, Regenerative Med. sold 27,329 shares at an average $3.44 ($94,069)
- 4 Open-market sale President, Regenerative Med. sold 8,503 shares at $4.04 ($34,344)
- 4 Open-market sale President, WC & Surgical sold 12,343 shares at $4.21 ($51,939)
- 4 Open-market sale President, Regenerative Med. sold 19,500 shares at $3.62 ($70,590)
- 4 Open-market sale President, Regenerative Med. sold 14,600 shares at $3.47 ($50,662)
- 4 Open-market sale Chief Executive Officer sold 112,000 shares at $3.75 ($420,000)
- 4 Grant or award Director acquired 44,191 shares (grant or award)
- 4 Grant or award Director acquired 44,191 shares (grant or award)
- 4 Grant or award Director acquired 44,191 shares (grant or award)
- 4 Grant or award Director acquired 44,191 shares (grant or award)
- 4 Grant or award Director acquired 44,191 shares (grant or award)
- 4 Grant or award Director acquired 44,191 shares (grant or award)
- 4 Grant or award Director acquired 44,191 shares (grant or award)
Page 6 of 30 · 584 filings